Sofosbuvir/Ledipasvir for Hepatitis C Genotype 1-6 in Patients With Transfusion-Dependent Thalassemia: An Open Label Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03032666

Recruitment Status : Completed

First Posted : January 26, 2017

Last Update Posted : October 11, 2018

Sponsor:

Collaborator:

Gilead Sciences

Information provided by (Responsible Party):

Ala'a Sharara, American University of Beirut Medical Center

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Actual Primary Completion Date :	August 6, 2018
Actual Study Completion Date :	August 6, 2018

To Top